OVN.AU · Oventus Medical Limited

-

Please sign in to comment on OVN.AU

1 Comment

Admin

4 years, 1 month ago

Oventus Medical Limited is currently in a long term downtrend where the price is trading 43.3% below its 200 day moving average.

From a valuation standpoint, the stock is 85.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 37.3.

Oventus Medical Limited's total revenue rose by 192.0% to $550K since the same quarter in the previous year.

Its net income has increased by 8.7% to $-5M since the same quarter in the previous year.

Finally, its free cash flow grew by 56.1% to $-1M since the same quarter in the previous year.

Based on the above factors, Oventus Medical Limited gets an overall score of 4/5.

Exchange	AU
CurrencyCode	AUD
Sector	Healthcare
Industry	Medical Devices
ISIN	AU000000OVN3

Market Cap	5M
PE Ratio	0.0
Dividend Yield	0.0%
Target Price	0.14
Beta	0.67

ABOUT

Oventus Medical Limited

Oventus Medical Limited, a medical device company, engages in the development and commercialization of oral appliances for the treatment of obstructive sleep apnoea (OSA) and snoring in Australia, Canada, and the United States. The company offers O2Vent Optima, a 3D-printed nylon oral appliance for OSA patients; and ExVent, a valve accessory that fits into the open airway of the O2Vent Optima device. The company was incorporated in 2015 and is headquartered in Indooroopilly, Australia.

OVN.AU · Oventus Medical Limited

-

Oventus Medical Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Oventus Medical Limited using a moving average strategy